RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,000 | -33.3% | 584 | -46.5% | 0.00% | – |
| Q2 2023 | $3,000 | 0.0% | 1,092 | -32.7% | 0.00% | – |
| Q1 2023 | $3,000 | -91.7% | 1,622 | -84.2% | 0.00% | – |
| Q4 2022 | $36,000 | -85.4% | 10,291 | +54.6% | 0.00% | – |
| Q3 2022 | $246,000 | +100.0% | 6,658 | +2.7% | 0.00% | – |
| Q2 2022 | $123,000 | -42.0% | 6,484 | -17.5% | 0.00% | – |
| Q1 2022 | $212,000 | -1.4% | 7,856 | -17.6% | 0.00% | – |
| Q4 2021 | $215,000 | -16.3% | 9,537 | -2.8% | 0.00% | – |
| Q3 2021 | $257,000 | -15.7% | 9,811 | +3.0% | 0.00% | – |
| Q2 2021 | $305,000 | -6.4% | 9,527 | +2.7% | 0.00% | – |
| Q1 2021 | $326,000 | -58.4% | 9,277 | -62.0% | 0.00% | – |
| Q4 2020 | $783,000 | -14.8% | 24,399 | -0.1% | 0.00% | – |
| Q3 2020 | $919,000 | +91800.0% | 24,426 | +93846.2% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 26 | -27.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 853,206 | $30,041,000 | 3.26% |
| COMMODORE CAPITAL LP | 161,565 | $5,689,000 | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $7,042,000 | 1.98% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 451,412 | $15,894,000 | 1.30% |
| Avoro Capital Advisors LLC | 1,525,000 | $53,695,000 | 0.93% |
| RTW INVESTMENTS, LP | 1,530,717 | $53,897,000 | 0.84% |
| Pegasus Asset Management, Inc. | 26,958 | $949,000 | 0.48% |
| COWEN AND COMPANY, LLC | 166,942 | $5,878,000 | 0.40% |
| Ikarian Capital, LLC | 290,207 | $10,218,000 | 0.34% |
| Spotlight Asset Group, Inc. | 24,565 | $865,000 | 0.32% |